The Value of Patient Reporting of Adverse Drug Reactions to Pharmacovigilance Systems

Show simple item record Inácio, Pedro 2018-09-14T05:00:26Z 2018-09-18 2018-09-14T05:00:26Z 2018-09-28
dc.identifier.uri URN:ISBN:978-951-51-4500-0
dc.description.abstract Patient reporting of adverse drug reactions (ADRs) has become an important element of pharmacovigilance. The aim of this thesis was to research the value of patient reporting of ADRs to pharmacovigilance systems. The study consists of 4 original studies, of which study I and II are interrelated. Study I identified which are the clinical and subjective aspects of adverse drug reactions (ADRs) that patients provide. A literature review covered peer-reviewed literature published in English until January 2015, in a total of 34 studies. Main results supported patient reporting having the advantages of bringing novel information about ADRs. Patients provide a more detailed description of ADRs and report about different medicines, system organ classes and effects when compared with health care providers (HCPs). In addition, patients describe the severity and impact of ADRs on daily life, complementing information derived from HCPs. Patient reporting is still relatively rare in most countries. This study concluded that patient reporting adds new information, and perspective about ADRs in a way otherwise unavailable. The opinions and experiences of different stakeholders on the role of direct patient reporting were explored through a series of qualitative interviews in selected countries (Study II). Participants from countries introducing patient reporting recently expressed a more negative attitude. All participants highlighted the need for additional resources, both human and financial, to address patient reporting and associated advantages. The findings identified perceived barriers and facilitators of patient reporting, such as the engagement of patients, use of information and dissemination of patient reporting. Study III analyzed the correlation between several sociodemographic and economic factors and direct patient reporting rate in diverse countries. The study was based on the hypothesis that a higher human development index is related with a higher reporting rate and patient involvement in their health status. Health investment indicators, such as per capita public health expenditure, hospital bed density and under-five mortality rate categories were the relevant factors to discriminate countries that have higher patient reporting rates. Although general, these results point that to reach better patient involvement in the pharmacovigilance system it is preferable to invest in public health education rather than to have more sophisticated pharmacovigilance systems designed to capture all patients’ inputs. Study IV aimed to assess the degree of variation of language used by HCPs when describing ADRs and to compare it with the corresponding Medical Dictionary of Regulatory Activities (MedDRA) codes. The study concluded that lexical and semantic distances between spontaneous reports and coded terms by MedDRA exist, as well as between different groups of HCPs. These differences may interfere with the strength of a generated safety signal, which places more value into having additional source of ADRs information e.g. from the patients. In this context, HCPs can be seen as bench-markers, while assessing the pharmacovigilance system maturity. en
dc.description.abstract fi
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Helsingin yliopisto fi
dc.publisher Helsingfors universitet sv
dc.publisher University of Helsinki en
dc.relation.isformatof URN:ISBN:978-951-51-4499-7
dc.rights Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty. fi
dc.rights This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited. en
dc.rights Publikationen är skyddad av upphovsrätten. Den får läsas och skrivas ut för personligt bruk. Användning i kommersiellt syfte är förbjuden. sv
dc.title The Value of Patient Reporting of Adverse Drug Reactions to Pharmacovigilance Systems en
dc.type.ontasot Doctoral dissertation (article-based) en
dc.type.ontasot Artikkeliväitöskirja fi
dc.type.ontasot Artikelavhandling sv
dc.ths Airaksinen, Marja
dc.ths Cavaco, Afonso
dc.opn Cordina, Maria
dc.type.dcmitype Text
dc.contributor.organization University of Helsinki, Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy en
dc.contributor.organization Doctoral Programme in Drug Research en
dc.contributor.organization Helsingin yliopisto, farmasian tiedekunta fi
dc.contributor.organization Lääketutkimuksen tohtoriohjelma fi
dc.contributor.organization Helsingfors universitet, farmaceutiska fakulteten sv
dc.contributor.organization Doktorandprogrammet i läkemedelsforskning sv
dc.type.publication doctoralThesis

Files in this item

Total number of downloads: Loading...

Files Size Format View
THEVALUE.pdf 1.712Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record